Careen Yen Lowder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Careen Yen Lowder has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Francesco Pichi
San Giuseppe Hospital-University Eye Clinic
4 shared publicationsDavid M. Meisler
3 shared publications- Francesco Pichi
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada
3 shared publications Austen N. Knapp
Cole Eye Institute, Cleveland Clinic, Cleveland, USA
2 shared publicationsBrandy C. Hayden
Cleveland Clinic Cole Eye Institute, Cleveland, Ohio
2 shared publicationsCaroline C. Awh
Cole Eye Institute, Cleveland Clinic, Cleveland, USA
2 shared publications
Latest Publications
- Open Access
- 23 October 2024
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 14 (1) , 1-6
Foscarnet eyedrops for the treatment of refractory herpetic keratitis
Purpose: The purpose of this case series is to describe the clinical course of patients receiving foscarnet eyedrops for the treatment of refractory herpetic keratitis. Observations: Six patients diagnosed with herpetic keratitis were treated with foscarnet 24 mg/mL (2.4%) eyedrops with resulting improvement in keratitis. Conclusion: Topical foscarnet may be a safe and effective treatment for herpetic keratitis in conjunction with, or as an alternative to, conventional antiviral therapy. This is an off-label use of foscarnet.
- 23 October 2024
- Published by Springer Nature in Journal of Ophthalmic Inflammation and Infection
- Vol. 14 (1) , 1-6
Open AccessFoscarnet eyedrops for the treatment of refractory herpetic keratitis
Purpose: The purpose of this case series is to describe the clinical course of patients receiving foscarnet eyedrops for the treatment of refractory herpetic keratitis. Observations: Six patients diagnosed with herpetic keratitis were treated with foscarnet 24 mg/mL (2.4%) eyedrops with resulting improvement in keratitis. Conclusion: Topical foscarnet may be a safe and effective treatment for herpetic keratitis in conjunction with, or as an alternative to, conventional antiviral therapy. This is an off-label use of foscarnet.
- Open Access
- 20 July 2023
- Published by Springer Nature in Research Square
Foscarnet eyedrops for the treatment of refractory herpetic keratitis
Purpose The purpose of this case series is to describe the clinical course of patients receiving foscarnet eyedrops for the treatment of refractory herpetic keratitis. Observations: Six patients diagnosed with herpetic keratitis were treated with foscarnet 24 mg/mL (2.4%) eyedrops with resulting improvement in keratitis. Conclusion Topical foscarnet may be a safe and effective treatment for herpetic keratitis in conjunction with, or as an alternative to, conventional antiviral therapy. This is an off-label use of foscarnet.
- 20 July 2023
- Published by Springer Nature in Research Square
Open AccessFoscarnet eyedrops for the treatment of refractory herpetic keratitis
Purpose The purpose of this case series is to describe the clinical course of patients receiving foscarnet eyedrops for the treatment of refractory herpetic keratitis. Observations: Six patients diagnosed with herpetic keratitis were treated with foscarnet 24 mg/mL (2.4%) eyedrops with resulting improvement in keratitis. Conclusion Topical foscarnet may be a safe and effective treatment for herpetic keratitis in conjunction with, or as an alternative to, conventional antiviral therapy. This is an off-label use of foscarnet.
- 17 March 2023
- Published by Springer Nature
- p. 39-52
Syphilis: Emerging Ocular Infections
- 14 December 2022
- Published by Springer Nature
- p. 75-78
Neovascular Glaucoma in Ocular Inflammatory Disease
- 14 December 2022
- Published by Springer Nature
- p. 75-78
Neovascular Glaucoma in Ocular Inflammatory Disease
- Open Access
- 1 December 2020
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 20, 100962
Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine
- 1 December 2020
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 20, 100962
Open AccessAcute retinal necrosis following recombinant subunit varicella-zoster virus vaccine
- Open Access
- 1 September 2020
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 19, 100763
Visual recovery and vascular reperfusion after vaso-occlusive retinopathy from anti-phospholipid syndrome associated with systemic lupus erythematosus
- 1 September 2020
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 19, 100763
Open AccessVisual recovery and vascular reperfusion after vaso-occlusive retinopathy from anti-phospholipid syndrome associated with systemic lupus erythematosus
- 28 January 2020
- Published by Springer Nature
- p. 35-39
Iris Complications in Uveitis
- Open Access
- 3 September 2019
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rheumatology
- Vol. 5 (3) , 165-168
Characteristics of inflammatory eye disease associated with hidradenitis suppurativa
Objective: Hidradenitis suppurativa (HS) is an inflammatory skin condition that can cause profound morbidity. Patients can present with recurrent nodules, sinus tract formation, abscesses, and/or scarring, mainly affecting the intertriginous areas. Case reports have documented the coexistence of HS and inflammatory eye disease (IED). Herein, we aimed to assess the types of IED associated with HS and the outcomes of IED treatment in patients with HS. Methods: All the cases with a diagnosis of HS and any IED were identified. Patients with episcleritis and sicca were excluded, and only those with chronic IED were included. An independent ophthalmologist reviewed notes to ensure accuracy of IED diagnosis. Demographics, IED patterns, comorbidities, treatments, and outcomes were retrieved from patient charts. Results: Twenty patients [16 females (80%); 12 African Americans (60%)] were included in this study after the exclusion of 436 cases due to lack of data. The mean age at the diagnosis of HS and IED was 42.1 and 43.6 years, respectively. Thirteen patients had uveitis (65%), six had scleritis (30%), and one had peripheral ulcerative keratitis. Thirteen out of 20 patients (65%) had multiple autoimmune and/or inflammatory comorbidities, including inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, and lupus. Seven patients (35%) did not have any comorbid inflammatory/autoimmune conditions. Conclusion: One-third of the patients with HS and IED did not have any autoimmune or inflammatory comorbidity that could explain the eye involvement. The potential association between HS and IED might be a manifestation of a common immune dysregulation phenomenon. Furthermore, the management of IED required an escalation of therapy to systemic immunosuppressive agents in 70% of patients with HS. Cite this article as: Saygın D, Syed AU, Lowder CY, Srivastava S, Maya JJ, Hajj-Ali RA. Characteristics of inflammatory eye disease associated with hidradenitis suppurativa. Eur J Rheumatol 2018; 5(3): 165-8.
- 3 September 2019
- Published by AVES YAYINCILIK A.Ş. in European Journal of Rheumatology
- Vol. 5 (3) , 165-168
Open AccessCharacteristics of inflammatory eye disease associated with hidradenitis suppurativa
Objective: Hidradenitis suppurativa (HS) is an inflammatory skin condition that can cause profound morbidity. Patients can present with recurrent nodules, sinus tract formation, abscesses, and/or scarring, mainly affecting the intertriginous areas. Case reports have documented the coexistence of HS and inflammatory eye disease (IED). Herein, we aimed to assess the types of IED associated with HS and the outcomes of IED treatment in patients with HS. Methods: All the cases with a diagnosis of HS and any IED were identified. Patients with episcleritis and sicca were excluded, and only those with chronic IED were included. An independent ophthalmologist reviewed notes to ensure accuracy of IED diagnosis. Demographics, IED patterns, comorbidities, treatments, and outcomes were retrieved from patient charts. Results: Twenty patients [16 females (80%); 12 African Americans (60%)] were included in this study after the exclusion of 436 cases due to lack of data. The mean age at the diagnosis of HS and IED was 42.1 and 43.6 years, respectively. Thirteen patients had uveitis (65%), six had scleritis (30%), and one had peripheral ulcerative keratitis. Thirteen out of 20 patients (65%) had multiple autoimmune and/or inflammatory comorbidities, including inflammatory bowel disease, rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, and lupus. Seven patients (35%) did not have any comorbid inflammatory/autoimmune conditions. Conclusion: One-third of the patients with HS and IED did not have any autoimmune or inflammatory comorbidity that could explain the eye involvement. The potential association between HS and IED might be a manifestation of a common immune dysregulation phenomenon. Furthermore, the management of IED required an escalation of therapy to systemic immunosuppressive agents in 70% of patients with HS. Cite this article as: Saygın D, Syed AU, Lowder CY, Srivastava S, Maya JJ, Hajj-Ali RA. Characteristics of inflammatory eye disease associated with hidradenitis suppurativa. Eur J Rheumatol 2018; 5(3): 165-8.
- 22 April 2017
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (2) , 829-832
Herpes zoster keratitis development after acute retinal necrosis
To report a case of herpes zoster keratitis in a patient undergoing treatment for herpetic acute retinal necrosis.
- 22 April 2017
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (2) , 829-832
Herpes zoster keratitis development after acute retinal necrosis
To report a case of herpes zoster keratitis in a patient undergoing treatment for herpetic acute retinal necrosis.
- 28 July 2016
- Published by Springer Nature
- p. 251-258
Pediatric Masquerade Uveitis